The International Myeloma Working Group (IMWG) has recently published a consensus statement in the Journal of Clinical Oncology recommending the use of magnetic resonance imaging (MRI) in myeloma. It recommends that all symptomatic and asymptomatic patients undergo whole-body MRI (or spinal and pelvic if whole-body MRI is not available) to detect bone marrow involvement and to evaluate painful lesions. Importantly, asymptomatic patients with more than one unequivocal focal lesion detected by MRI will now be classified as having symptomatic myeloma and require treatment in line with the IMWG’s new diagnostic criteria for myeloma published late last year. These recommendations are the outcome of a review of published data on the use of MRI in myeloma and have brought to light the value of MRI in the management of the disease.


Read full article